Laboratory-based evaluation of the 4th-generation AlereTM HIV Combo rapid point-of-care test
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0298912 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Alice Manjate und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden. Hauptthemen laut MEDLINE: HIV Infections, HIV Seropositivity, HIV-1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish International Development Cooperation Agency.
Abstract (Originalsprache)
Background
Mozambique is a high-prevalence country for HIV and early detection of new HIV infections is crucial for control of the epidemic. We aimed to evaluate the accuracy of the 4 th -generation rapid diagnostic test (RDT) Alere TM HIV Combo in detecting acute and seroconverted HIV-infection, among sexually-active women attending three clinical health centers in Maputo, Mozambique.
Methods
Women aged 14–55 years (n = 920) seeking care at the Mavalane Health Area, Maputo (February 2018-January 2019) were included, and blood specimens sampled. Sociodemographic and sexual behavior data were collected. Point-of-care HIV testing was performed using Alere Determine TM HIV-1/2 and Uni-Gold TM HIV-1/2. All samples were also tested using Enzygnost® HIV Integral 4 and Innotest® HIV Antigen mAb in laboratory. The 4 th -generation RDT Alere TM HIV Combo was evaluated on serum samples in the laboratory. Finally, Innotest® HIV Antigen mAb, Enzygnost® HIV Integral 4 (Ag/Ab), and HIV RNA quantification acted as gold standard assays in the evaluation of Alere TM HIV Combo test for HIV antigen detection (in clinical samples and in three HIV-1 seroconversion panels).
Results
The antibody component of the 4th generation Alere TM HIV Combo RDT demonstrated a sensitivity and specificity of 100% examining clinical samples. However, the test did not detect HIV p24 antigen in any clinical samples, while Innotest® HIV Antigen mAb, verified by Enzygnost® HIV Integral 4 (Ag/Ab) and/or HIV RNA quantification, detected HIV antigen in six clinical samples. Furthermore, the Alere TM HIV Combo RDT had a low sensitivity in the detection of HIV p24 antigen in seroconversion panels. The HIV prevalence among the examined women was 17.8%.
Conclusions
The 4 th -generation RDT Alere TM HIV Combo showed similar sensitivity to the 3 rd -generation RDTs to detect seroconverted HIV-infections. However, the sensitivity for detection of HIV p24 antigen and diagnosing acute HIV infections, before seroconversion, was low. There is an urgent need to develop and evaluate simple and affordable POC tests with high sensitivity and specificity for diagnosing individuals with acute HIV infection in resource-limited settings with high HIV prevalence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
- Faculdade de Medicina, Departamento de Microbiologia, Universidade Eduardo Mondlane, Maputo, Mozambique.
- Public Health Agency of Sweden, Stockholm, Sweden.
- Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
- Faculty of Medicine and Health, Department of Laboratory Medicine, WHO Collaborating Centre for Gonorrhoea and Other STIs, Microbiology, Örebro University, Örebro, Sweden.
- Institute for Global Health, University College London (UCL), London, United Kingdom.
ORCID-Profile: Sarah Lindroth, Jahit Sacarlal, Magnus Unemo
Förderung
- Swedish International Development Cooperation Agency
Zitieren
APA
Manjate, A., Nilsson, C., Axelsson, M., Lindroth, S., Sirbu, D., Sacarlal, J., Andersson, S., & Unemo, M. (2024). Laboratory-based evaluation of the 4th-generation AlereTM HIV Combo rapid point-of-care test. PLOS ONE. https://doi.org/10.1371/journal.pone.0298912
Vancouver
Manjate A, Nilsson C, Axelsson M, Lindroth S, Sirbu D, Sacarlal J, et al. Laboratory-based evaluation of the 4th-generation AlereTM HIV Combo rapid point-of-care test. PLOS ONE. 2024. doi:10.1371/journal.pone.0298912
BibTeX
@article{Manjate2024,
author = {Manjate, Alice and Nilsson, Charlotta and Axelsson, Maria and Lindroth, Sarah and Sirbu, Desiree and Sacarlal, Jahit and Andersson, Sören and Unemo, Magnus},
title = {Laboratory-based evaluation of the 4th-generation AlereTM HIV Combo rapid point-of-care test},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0298912}
}
EUVIMED